The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia

被引:71
作者
Lynch, A. M. [1 ]
Murphy, J. R. [2 ]
Gibbs, R. S. [1 ]
Levine, R. J. [3 ]
Giclas, P. C. [4 ]
Salmon, J. E. [5 ]
Holers, V. M. [6 ,7 ]
机构
[1] Univ Colorado, Denver Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
[4] Natl Jewish Hlth, Div Allergy & Immunol, Dept Pediat, Denver, CO USA
[5] Hosp Special Surg, Weill Cornell Med Ctr, New York, NY 10021 USA
[6] Univ Colorado, Denver Sch Med, Div Rheumatol, Dept Med, Aurora, CO 80045 USA
[7] Univ Colorado, Denver Sch Med, Div Rheumatol, Dept Immunol, Aurora, CO 80045 USA
关键词
Angiogenesis-related factors; complement-activating factors; obesity; pre-eclampsia; PLACENTAL GROWTH-FACTOR; INTRAUTERINE GROWTH; ANTIANGIOGENIC FACTORS; ALTERNATIVE PATHWAY; SOLUBLE ENDOGLIN; RISK; IMMUNOLOGY; LIPODYSTROPHY; RESTRICTION; OBESITY;
D O I
10.1111/j.1471-0528.2009.02473.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To determine the interrelationships during early pregnancy of complement-activation fragments Bb, C3a and sC5b-9, and angiogenesis-related factors placental growth factor (PiGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), and their associations with pre-eclampsia. Design Prospective cohort study. Setting Denver complement study (June 2005-June 2008). Population A total of 668 pregnant women with singleton gestations, recruited between 10 and 15 weeks of gestation. Methods Using univariable and multivariable logistic regression analysis, concentrations of complement-activation fragments and angiogenesis-related factors were compared between 10 and 15 weeks of gestation in women who subsequently did or did not develop pre-eclampsia. Interrelationships between these variables were tested using the non-parametric Spearman rank correlation coefficient. Main outcome measure Pre-eclampsia. The association of complement-activation fragments and angiogenesis-related factors with obesity was also examined. Results The mean (+/-SD) levels of complement Bb in early pregnancy among women who did and did not develop pre-eclampsia were 0.84 (+/-0.26) mu g/ml and 0.69 (+/-0.2) mu g/ml, respectively (P = 0.001). Concentrations of PiGF were significantly (P = 0.01) lower (31 +/- 12 pg/ml) in early pregnancy in the pre-eclamptic group of women, as compared with the normotensive group (39 +/- 32 pg/ml). The adjusted odds ratio (AOR) of Bb and PiGF were 2.1 (CI = 1.4-3.1, P < 0.0003) and 0.2 (CI = 0.07-0.7, P = 0.01), respectively. There was no significant difference in the levels of C3a, sC5b-9, sFlt-1 and sEng in early pregnancy among women who developed pre-eclampsia, compared with women who remained normotensive during pregnancy. Higher levels of Bb (P = 0.0001) and C3a (P = 0.03), and lower levels of sFlt-1 (P = 0.0002) and sEng (P = 0.0001) were found among women with obesity, compared with non-obese controls. No meaningful relationships were found between the complement-activation fragments and the angiogenesis-related factors. Conclusions In this cohort during early pregnancy, increased concentrations of complement-activation factor Bb and lower concentrations of PiGF were associated with the development of pre-eclampsia later in pregnancy.
引用
收藏
页码:456 / 462
页数:7
相关论文
共 37 条
[1]   Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta [J].
Challier, J. C. ;
Basu, S. ;
Bintein, T. ;
Minium, J. ;
Hotmire, K. ;
Catalano, P. M. ;
Mouzon, S. Hauguel-de .
PLACENTA, 2008, 29 (03) :274-281
[2]  
CHOY LN, 1992, J BIOL CHEM, V267, P12736
[3]   Pre-eclampsia: Is the immune maladaptation hypothesis still standing? An epidemiological update [J].
Dekker, Gus ;
Robillard, Pierre-Yves .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 76 (1-2) :8-16
[4]   Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction [J].
Girardi, Guillermina ;
Yarilin, Dmitry ;
Thurman, Joshua M. ;
Holers, V. Michael ;
Salmon, Jane E. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (09) :2165-2175
[5]   The spectrum of complement alternative pathway-mediated diseases [J].
Holers, V. Michael .
IMMUNOLOGICAL REVIEWS, 2008, 223 :300-316
[6]   The alternative pathway of complement in disease: opportunities for therapeutic targeting [J].
Holers, VM ;
Thurman, JM .
MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) :147-152
[7]  
Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116
[8]   Preeclampsia - A pressing problem: An executive summary of a national institute of child health and human development workshop [J].
Ilekis, John V. ;
Reddy, Uma M. ;
Roberts, James M. .
REPRODUCTIVE SCIENCES, 2007, 14 (06) :508-523
[9]   Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia [J].
Jeyabalan, Arun ;
Powers, Robert W. ;
Durica, Allison R. ;
Harger, Gail F. ;
Roberts, James M. ;
Ness, Roberta B. .
AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (08) :943-947
[10]   Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [J].
Levine, Richard J. ;
Lam, Chun ;
Qian, Cong ;
Yu, Kai F. ;
Maynard, Sharon E. ;
Sachs, Benjamin P. ;
Sibai, Baha M. ;
Epstein, Franklin H. ;
Romero, Roberto ;
Thadhani, Ravi ;
Karumanchi, S. Ananth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :992-1005